DarioHealth (DRIO) reported Q3 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $6.61 million versus the consensus estimate of $6.29 million.
DarioHealth (DRIO) reported Q3 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $6.61 million versus the consensus estimate of $6.29 million.